Has Ana Clara Smith received payments from drug or device companies?

Yes. Drug and device makers reported $2,957 in general payments to Ana Clara Smith across 144 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ana Clara Smith did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ana Clara Smith come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ana Clara Smith

Psychiatry · Durham, NCNPI 1437316916

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.1% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations.

$2,957in general payments, 2019–2025

Across 144 payments — averaging $20.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Vanda Pharmaceuticals Inc.$508
AbbVie$426
Otsuka America Pharmaceutical, Inc.$379
Axsome Therapeutics, Inc.$278
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$247
Lundbeck LLC$184
plus $935 from 14 others

What the payments were for

Food & beverage$2,92999%
Education$271%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Vanda Pharmaceuticals Inc.	24	$508
AbbVie(2 entities)	22	$426
Otsuka America Pharmaceutical, Inc.	20	$379
Axsome Therapeutics, Inc.	9	$278
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	13	$247
Lundbeck LLC	7	$184
Johnson & Johnson	10	$174
E.r. Squibb & Sons, L.L.C.	5	$121
Takeda Pharmaceuticals U.S.A., Inc.	6	$114
Indivior Inc.	5	$81
Supernus Pharmaceuticals, Inc.	3	$80
Alkermes, Inc.	4	$75
Shire North American Group Inc	4	$69
Teva Pharmaceuticals USA, Inc.	3	$46
Otsuka Pharmaceutical Development & Commercialization, Inc.	2	$43
Ironshore Pharmaceuticals Inc.	2	$40
Neurocrine Biosciences, Inc.	2	$38
Collegium Pharmaceutical, Inc.	1	$22
Bausch Health US, LLC	1	$17
Tris Pharma Inc	1	$14

How this compares

$2,957 in reported general payments places this provider in the 85th percentile of 1,108 psychiatry providers in North Carolina.

See all psychiatry providers in North Carolina →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lisdexamfetamine Dimesylate	11	$3,076
Venlafaxine Hcl ErVenlafaxine Hcl	12	$506
Guanfacine Hcl ErGuanfacine Hcl	11	$53

Paid to pharmacies, not to this prescriber.

Other psychiatry in Durham

Mark ReynoldsDurham$3.2M
Steven SzaboDurham$360K
Andrew KrystalDurham$234K
Ranjan SudanDurham$81K
Caleb WhitenackDurham$68K
Paolo MannelliDurham$38K
P DoraiswamyDurham$35K
David JarrettDurham$28K
Steven PrakkenDurham$22K
Mustafa HusainDurham$20K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →